AnitaH.ClaytonMD
Psychiatry • Charlottesville, VAProfessor, Psychiatric Medicine, University of Virginia School of Medicine
Dr. Clayton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2955 Ivy Rd
Charlottesville, VA 22903Phone+1 434-243-4646Fax+1 434-243-4743
Education & Training
University of Virginia Medical CenterResidency, Psychiatry, 1985 - 1988- University of Virginia Medical CenterInternship, Transitional Year, 1982 - 1983
University of Virginia School of MedicineClass of 1982
Certifications & Licensure
VA State Medical License 1985 - 2026
IL State Medical License 1983 - 1984- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012
Clinical Trials
- Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response Start of enrollment: 2009 Sep 01
- Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction? Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- Effects of Gepirone-ER on Sexual Function in Patients With Major Depressive Disorder.Tierney K Lorenz, Mary F Johnson, Anita H Clayton
The Journal of Clinical Psychiatry. 2024-10-21 - 2 citationsThe magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: An integrat...Anita H Clayton, Ellison Suthoff, Rakesh Jain, Mark Kosinski, Moshe Fridman
Journal of Affective Disorders. 2024-04-15 - Outpatient Pharmacogenomic Screenings to Prevent Addiction, Overdose, and Suicide.Atmaram Yarlagadda, Kevin Swift, Nabarun Chakraborty, Rasha Hammamieh, Amina Abubakar
Innovations in Clinical Neuroscience. 2023-12-01
Press Mentions
Zuranolone Effective in Major DepressionMay 10th, 2023- Sage Therapeutics and Biogen Announce Consistent Clinically Meaningful Data for Zuranolone Across the LANDSCAPE and NEST Clinical Development Programs Presented at the European College of Neuropsychopharmacology (ECNP) CongressOctober 4th, 2021
- Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Launches the Desire Project to Promote MDMA-Assisted Psychotherapy Treatment for HSDDOctober 1st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
